Switching Between Second-Generation AntipsychoticsWhy and How?

被引：0
作者：
Monika Edlinger
Susanne Baumgartner
Nadja Eltanaihi-Furtmüller
Martina Hummer
W. Wolfgang Fleischhacker
机构：
[1] Innsbruck Medical University,Department of Biological Psychiatry
来源：
CNS Drugs | 2005年 / 19卷
关键词：
Clozapine; Risperidone; Olanzapine; Quetiapine; Negative Symptom;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The introduction of second-generation antipsychotics represents an important advance in the treatment of schizophrenia. Although these drugs are generally very effective, not all patients respond in the same way. Partial response with persistent positive and negative symptoms and residual symptoms may force physicians to change antipsychotic medication. As more and more second-generation antipsychotics are introduced, the need for practical guidelines on switching these medications becomes increasingly important.
引用
收藏
页码：27 / 42
页数：15
相关论文
共 50 条
[21]   Diabetes and second-generation (atypical) antipsychotics [J].
Chabroux, S. ;
Haffen, E. ;
Penfornis, A. .
ANNALES D ENDOCRINOLOGIE, 2009, 70 (04) :202-210
[22]   Changes in serum thyroid hormone levels in psychiatric patients treated with second-generation antipsychotics [J].
Zhang, Jia-Xuan ;
Li, Xun .
ENDOKRYNOLOGIA POLSKA, 2020, 71 (04) :292-298
[23]   Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics [J].
Raebel, Marsha A. ;
Penfold, Robert ;
McMahon, Ann W. ;
Reichman, Marsha ;
Shetterly, Susan ;
Goodrich, Glenn ;
Andrade, Susan ;
Correll, Christoph U. ;
Gerhard, Tobias .
PEDIATRICS, 2014, 134 (05) :E1308-E1314
[24]   Second-generation antipsychotics for schizophrenia: can we resolve the conflict? [J].
Leucht, S. ;
Kissling, W. ;
Davis, J. M. .
PSYCHOLOGICAL MEDICINE, 2009, 39 (10) :1591-1602
[25]   Effectiveness of second-generation antipsychotics with acute-phase schizophrenia [J].
Hatta, Kotaro ;
Sato, Koji ;
Hamakawa, Hiroshi ;
Takebayashi, Hiroshi ;
Kimura, Naoto ;
Ochi, Shinichiro ;
Sudo, Yasuhiko ;
Asukai, Nozomu ;
Nakamura, Hiroyuki ;
Usui, Chie ;
Kawabata, Toshitaka ;
Hirata, Toyoaki ;
Sawa, Yutaka .
SCHIZOPHRENIA RESEARCH, 2009, 113 (01) :49-55
[26]   A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia [J].
Leucht, Stefan ;
Komossa, Katja ;
Rummel-Kluge, Christine ;
Corves, Caroline ;
Hunger, Heike ;
Schmid, Franziska ;
Lobos, Claudia Asenjo ;
Schwarz, Sandra ;
Davis, John M. .
AMERICAN JOURNAL OF PSYCHIATRY, 2009, 166 (02) :152-163
[27]   Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia [J].
Addington, Donald E. ;
Mohamed, Somaia ;
Rosenheck, Robert A. ;
Davis, Sonia M. ;
Stroup, Thomas Scott ;
McEvoy, Joseph P. ;
Swartz, Marvin S. ;
Lieberman, Jeffrey A. .
JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (01) :75-80
[28]   Issues of choice in second-generation antipsychotic agents [J].
Teehan, M .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1998, 43 :7S-9S
[29]   Dose Equivalents for Second-Generation Antipsychotics: The Minimum Effective Dose Method [J].
Leucht, Stefan ;
Samara, Myrto ;
Heres, Stephan ;
Patel, Maxine X. ;
Woods, Scott W. ;
Davis, John M. .
SCHIZOPHRENIA BULLETIN, 2014, 40 (02) :314-326
[30]   Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder [J].
Citrome, Leslie ;
Reist, Christopher ;
Palmer, Liisa ;
Montejano, Leslie ;
Lenhart, Greg ;
Cuffel, Brian ;
Harnett, James ;
Sanders, Kafi N. .
SCHIZOPHRENIA RESEARCH, 2009, 108 (1-3) :238-244
12345